Integrating gene expression and clinical data to identify drug repurposing candidates for hyperlipidemia and hypertension

Abstract

Prioritizing drug repurposing candidates for downstream studies remains challenging. Here, the authors present a high-throughput approach to identify and validate drug repurposing candidates, integrating human gene expression, drug perturbation, and clinical data from publicly available resources.